Pfizer, Flagship join forces to hunt for 10 new drugs
Novartis axes secretive obesity program after high-risk, high-reward bet fails
Four crucial questions about the Humira biosimilar price war
Medicare's proposed coverage for Alzheimer's scan could be boon for Eisai and Biogen
*please scroll down for all the latest news*
